Recovery of Lung Function After 149 Days on Extracorporeal Membrane Oxygenation for COVID-19.

Autor:	Suero OR; Division of Cardiovascular Anesthesia, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Anesthesiology, The Texas Heart Institute, Houston, Texas., Valluri SK; Division of Cardiovascular Anesthesia, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas.; Division of Critical Care Medicine, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas., Farias-Kovac MH; Division of Cardiovascular Anesthesia, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Anesthesiology, The Texas Heart Institute, Houston, Texas., Simpson L; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Cardiology, The Texas Heart Institute, Houston, Texas., Loor G; Division of Cardiothoracic Transplantation and Circulatory Support, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Texas., Guerra DM; Division of Cardiovascular Anesthesia, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Anesthesiology, The Texas Heart Institute, Houston, Texas., Diaz-Gomez JL; Division of Cardiovascular Anesthesia, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Anesthesiology, The Texas Heart Institute, Houston, Texas., Chatterjee S; Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Texas.; Division of Trauma and Acute Care Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.; Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Jazyk:	angličtina
Zdroj:	Texas Heart Institute journal [Tex Heart Inst J] 2023 Oct 20; Vol. 50 (5).
DOI:	10.14503/THIJ-23-8132
Abstrakt:	This report highlights survival and the patient's perspective after prolonged venovenous extracorporeal membrane oxygenation (ECMO) for COVID-19-related respiratory failure. A 36-year-old man with COVID-19 presented with fever, anosmia, and hypoxia. After respiratory deterioration necessitating intubation and lung-protective ventilation, he was referred for ECMO. After 3 days of conventional venovenous ECMO, he required multiple creative cannulation configurations. Adequate sedation and recurrent bradycardia were persistent challenges. After 149 consecutive days of ECMO, he recovered native lung function and was weaned from mechanical ventilation. This represents the longest-duration ECMO support in a survivor of COVID-19 yet reported. Necessary strategies included unconventional cannulation and flexible anticoagulation. (© 2023 The Author(s). Published by The Texas Heart Institute®.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu